findmyKOL

Murali Chakinala, MD

Basic profile

University of Missouri–St. Louis

ORCID↗NPI↗
✓ Full record
RegionSaint Louis, MO · MidwestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: NationalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH funding2007–2007

Murali Chakinala is a Respiratory physician affiliated with University of Missouri–St. Louis. OpenAlex indexes 193 publications with 5,252 citations (h-index 40).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
193publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,252citations

Total citations across indexed works.

40h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2007–2007

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4921 Parkview Pl
Div Im Pulmonary And Ccm, 8th Fl
Saint Louis, MO 631101032

Telephone

314-454-8917

Registry record last updated 15 Apr 2025.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.7%
    Endothelin Receptor Antagonist22.9%
    Opsumit59%Ambrisentan35%Letairis6%
    Part D≥90 patients
    Loop diuretic9.9%
    Furosemide63%Bumetanide31%Torsemide6%
    Part D<11 patients

    + 8 more classes in this area

  • Genitourinary & hormones

    16%
    Phosphodiesterase 5 Inhibitor16%
    Tadalafil61%Sildenafil Citrate35%Adcirca5%
    Part D<11 patients
  • Metabolism & gastrointestinal

    11.1%
    Potassium supplement4.6%
    Potassium Chloride87%Klor-Con M209%Klor-Con4%
    Part D<11 patients
    Proton pump inhibitor2.3%
    Pantoprazole Sodium64%Omeprazole36%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)16.3% facility · 83.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2007–2007 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”